New Cancer Drug Uses Body's Own Cells To Blast Cancer

Cancer patients have seen their tumours blasted into submission by a new drug which harnesses the power of their own immune cells.

The 'serial killer' treatment completely eliminated some tumours and shrunk others resistant to existing therapies.

Further successful trials could lead to blinatumomab being on the market in less than five years.